These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3350045)

  • 21. Nucleus accumbens lesions reduce amphetamine hyperthermia but not hyperactivity.
    Wirtshafter D; Asin KE; Kent EW
    Eur J Pharmacol; 1978 Oct; 51(4):449-52. PubMed ID: 710513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low doses of accumbens dopamine modulate amygdala suppression of spontaneous exploratory activity in rats.
    Yim CY; Mogenson GJ
    Brain Res; 1989 Jan; 477(1-2):202-10. PubMed ID: 2649208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presynaptic modulation of dopamine-induced locomotor activity of oxotremorine in nucleus accumbens of the rat.
    de Belleroche JS; Winn P; Murzi E; Williams SF; Herberg LJ
    J Neural Transm; 1982; 54(3-4):134-43. PubMed ID: 6813423
    [No Abstract]   [Full Text] [Related]  

  • 24. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.
    Crawley JN; Hommer DW; Skirboll LR
    Brain Res; 1985 Jun; 335(2):337-41. PubMed ID: 4005562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat.
    Van den Bos R; Cools AR; Ogren SO
    Acta Physiol Scand; 1990 Mar; 138(3):423-4. PubMed ID: 2158210
    [No Abstract]   [Full Text] [Related]  

  • 26. Suppression of exploratory locomotor activity in the rat by the local application of 3-PPP enantiomers into the nucleus accumbens.
    Svensson L; Ahlenius S
    Eur J Pharmacol; 1983 Apr; 88(4):393-7. PubMed ID: 6861878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lesion of dopaminergic terminals in the amygdala produces enhanced locomotor response to D-amphetamine and opposite changes in dopaminergic activity in prefrontal cortex and nucleus accumbens.
    Simon H; Taghzouti K; Gozlan H; Studler JM; Louilot A; Herve D; Glowinski J; Tassin JP; Le Moal M
    Brain Res; 1988 May; 447(2):335-40. PubMed ID: 3134111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Septal lesions enhance hyperactivity induced either by amphetamine or lesions of the nucleus accumbens septi.
    Carey RJ
    Behav Brain Res; 1982 May; 5(1):43-52. PubMed ID: 7082466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of single and repeated doses of maprotiline, oxaprotiline and its enantiomers on foot-shock induced fighting in rats.
    Mogilnicka E; Boissard CG; Waldmeier PC; Delini-Stula A
    Pharmacol Biochem Behav; 1983 Oct; 19(4):719-23. PubMed ID: 6139826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropharmacological evidence to suggest that the nucleus accumbens and subpallidal region contribute to exploratory locomotion.
    Mogenson GJ; Nielsen M
    Behav Neural Biol; 1984 Sep; 42(1):52-60. PubMed ID: 6508693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections.
    Carr GD; White NM
    Life Sci; 1983 Dec; 33(25):2551-7. PubMed ID: 6645814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of chronic nicotine pretreatment on (+)-amphetamine and nicotine-induced synthesis and release of [3H]dopamine from [3H]tyrosine in rat nucleus accumbens.
    Fung YK
    J Pharm Pharmacol; 1989 Jan; 41(1):66-8. PubMed ID: 2565971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism by haloperidol of the suppression of exploratory locomotor activity induced by the local application of (-)3-(3-hydroxyphenyl)-N-n-propylpiperidine into the nucleus accumbens of the rat.
    Ahlenius S; Svensson L; Hillegaart V; Thorberg O
    Experientia; 1984 Aug; 40(8):858-9. PubMed ID: 6468602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of ventral pallidal neurons to amygdala stimulation and its modulation by dopamine projections to nucleus accumbens.
    Yim CY; Mogenson GJ
    J Neurophysiol; 1983 Jul; 50(1):148-61. PubMed ID: 6875644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shift from inhibition to excitation in the neostriatum but not in the nucleus accumbens following long-term amphetamine.
    Alloway KD; Rebec GV
    Brain Res; 1983 Aug; 273(1):71-9. PubMed ID: 6616234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens.
    Barnes JC; Costall B; Domeney AM; Naylor RJ
    Psychopharmacology (Berl); 1986; 89(3):311-6. PubMed ID: 3088656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nucleus accumbens and antidepressants: modulation of ergometrine-induced hyperactivity by typical and atypical antidepressants and neuroleptics in rats.
    Cools AR
    Psychopharmacology (Berl); 1987; 92(3):350-7. PubMed ID: 2888148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain.
    Jackson DM; Andén NE; Dahlström A
    Psychopharmacologia; 1975 Dec; 45(2):139-49. PubMed ID: 1215445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat.
    Van den Bos R; Cools AR; Ogren SO
    Acta Physiol Scand; 1989 Dec; 137(4):547-8. PubMed ID: 2557730
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections.
    Costall B; Domeney AM; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):27-33. PubMed ID: 6633677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.